Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16–50 years NA Kennedy, A Clark, A Walkden, JCW Chang, F Fascí-Spurio, M Muscat, ... Journal of Crohn's and Colitis 9 (1), 41-49, 2015 | 79 | 2015 |
Mucosal healing in inflammatory bowel disease: treatment efficacy and predictive factors C Papi, F Fascì-Spurio, F Rogai, A Settesoldi, G Margagnoni, V Annese Digestive and Liver Disease 45 (12), 978-985, 2013 | 74 | 2013 |
Early treatment in Crohn's disease: do we have enough evidence to reverse the therapeutic pyramid? FF Spurio, A Aratari, G Margagnoni, MT Doddato, C Papi Journal of Gastrointestinal & Liver Diseases 21 (1), 2012 | 50 | 2012 |
Faecal calprotectin and magnetic resonance enterography in ileal Crohn’s disease: correlations between disease activity and long-term follow-up GR Jones, F Fascì-Spurio, NA Kennedy, N Plevris, P Jenkinson, M Lyons, ... Journal of Crohn's and Colitis 13 (4), 442-450, 2019 | 25 | 2019 |
Low bioavailability and traditional systemic steroids in IBD: can the former take over the latter? F Fascì Spurio, A Aratari, G Margagnoni, V Clemente, A Moretti, C Papi Journal of Gastrointestinal & Liver Diseases 22 (1), 2013 | 25 | 2013 |
Natural history of ileo-caecal Crohn’s disease after surgical resection. A long term study G Margagnoni, A Aratari, M Mangone, A Moretti, A Spagnolo, ... Minerva Gastroenterol Dietol 57 (4), 335-344, 2011 | 17 | 2011 |
The problem of adherence to therapy in ulcerative colitis and the potential utility of multi-matrix system (MMX) technology C Bezzio, F Fascì-Spurio, C Viganò, G Meucci, C Papi, S Saibeni Expert Review of Gastroenterology & Hepatology 11 (1), 33-41, 2017 | 15 | 2017 |
Oral beclomethasone dipropionate: a critical review of its use in the management of ulcerative colitis and Crohn’s disease F Fascì Spurio, A Aratari, G Margagnoni, M Teresa Doddato, F Chiesara, ... Current Clinical Pharmacology 7 (2), 131-136, 2012 | 13 | 2012 |
The use of oral corticosteroids in inflammatory bowel diseases in Italy: an IG-IBD survey F Fascì-Spurio, G Meucci, C Papi, S Saibeni Digestive and Liver Disease 49 (10), 1092-1097, 2017 | 12 | 2017 |
Low bioavailability steroids in inflammatory bowel disease: an old chestnut or a whole new ballgame? S Saibeni, G Meucci, C Papi, G Manes, F Fascì-Spurio Expert Review of Gastroenterology & Hepatology 8 (8), 949-962, 2014 | 11 | 2014 |
Randomized controlled trials in prevention of postsurgical recurrence in Crohn's disease C Papi, F Fasci Spurio, G Margagnoni, A Aratari Reviews on Recent Clinical Trials 7 (4), 307-313, 2012 | 10 | 2012 |
Long term course of ulcerative colitis in the prebiologic era. A retrospective study in a tertiary referral center. G Margagnoni, F Fascì Spurio, L Feigusch, M Koch, C Papi, A Aratari Minerva gastroenterologica e dietologica 60 (4), 275-283, 2014 | 9 | 2014 |
Screening for active COVID-19 infection prior to biologic therapy in IBD patients: let's not increase our uncertainty without reducing our concerns S Festa, A Aratari, F De Biasio, F Fascì-Spurio, C Papi Digestive and Liver Disease 52 (11), 1246-1247, 2020 | 7 | 2020 |
564 Elevated Faecal Calprotectin Predicts Disease Progression in Crohn's Disease NA Kennedy, J Chang, M Guy, T Smith, JT Loh, D Haunschmidt, M Muscat, ... Gastroenterology 5 (144), S-105, 2013 | 6* | 2013 |
P221 Faecal calprotectin concentrations in Crohn's patients with ileal disease location: correlations with disease activity as seen by MRI enterography F Fascì-Spurio, A Chiappini, V Buonocore, S Cannizzaro, Z Maddalena, ... Journal of Crohn's and Colitis 8 (Supplement_1), S154-S155, 2014 | 4* | 2014 |
Sight-threatening Keratopathy Complicating Anti-TNF Therapy in Crohn's Disease: A Case Report F Fasci-Spurio, A Thompson, S Madill, P Koay, D Mansfield, J Satsangi Inflammatory Bowel Diseases 20 (1), E2-E3, 2014 | 4 | 2014 |
A new form of chronic inflammatory bowel disease associated with chronic liver disease F Fascì-Spurio, P Pavlidis, I Bjarnason Scandinavian Journal of Gastroenterology 51 (6), 644-645, 2016 | 2 | 2016 |
Is hospital admission an ideal condition for HCV screening? A survey from the Venetian area (north-east of Italy) A Caroli, I Franceschet, F Fascì-Spurio, L Girardi, R Cappuccio, ... Journal of Hepatology 73, S792, 2020 | 1 | 2020 |
P250 Elevated faecal calprotectin predicts disease progression in Crohn's disease NA Kennedy, J Chang, MH Guy, T Smith, JT Loh, D Haunschmidt, ... Journal of Crohn's and Colitis 7 (Supplement_1), S109-S110, 2013 | 1 | 2013 |
P266 Correlation of clinical symptoms to current biomarkers of intestinal inflammation in patients with Crohn's disease J Chang, N Kennedy, F Fascí Spurio, M Muscat, M Guy, J Satsangi, ... Journal of Crohn's and Colitis 7 (Supplement_1), S116-S116, 2013 | 1 | 2013 |